GlassScriptPhysician profile
Laurence R Bower
NPI 1659478303
$15,877.01
in general payments reported to CMS, 2019-2025
61 companies · $4,069 in 2025
The $4,069 reported for 2025 was more than what 83% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $685 · 2020: $1,073 · 2021: $2,004 · 2022: $2,737 · 2023: $3,171 · 2024: $2,137 · 2025: $4,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,242 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,241.51 |
| Education | $135.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,419.01 | 2021-2025 | Duopa, Qulipta, Ubrelvy |
| Novartis Pharmaceuticals Corporation | $1,313.30 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,264.44 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Acadia Pharmaceuticals INC | $1,072.04 | 2019-2025 | Nuplazid |
| Genentech USA, INC. | $671.89 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Lilly USA, LLC | $630.06 | 2020-2025 | Amyvid, Kisunla, Emgality |
| Neurocrine Biosciences, INC. | $581.65 | 2020-2025 | Ingrezza, Ongentys |
| Celgene Corporation | $565.25 | 2022-2025 | Zeposia |
| Pfizer INC. | $539.35 | 2021-2025 | |
| Lundbeck LLC | $516.61 | 2022-2025 | Vyepti, Rexulti |
| Sk Life Science, INC. | $510.62 | 2022-2025 | |
| Biogen, INC. | $510.13 | 2021-2025 | Vumerity, Tysabri, Leqembi |
| Abbott Laboratories | $500.25 | 2019-2025 | Infinity, Proclaim |
| Kyowa Kirin, INC. | $396.73 | 2020-2024 | Nourianz |
| Alexion Pharmaceuticals, INC. | $315.89 | 2019-2025 | Ultomiris |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $313.51 | 2020-2024 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $291.84 | 2023-2025 | Hyqvia, Gammagard |
| Neurelis, INC. | $288.23 | 2021-2024 | Valtoco |
| Tg Therapeutics, INC. | $280.92 | 2023-2025 | |
| Amgen INC. | $272.23 | 2020-2023 | Aimovig |
| Emd Serono, INC. | $248.47 | 2022-2025 | Mavenclad |
| Mdd US Operations, LLC | $241.27 | 2020-2025 | Gocovri |
| Eisai INC. | $240.84 | 2022-2025 | |
| Corium, LLC | $235.57 | 2022-2023 | Adlarity |
| Biohaven Pharmaceuticals, INC. | $228.62 | 2021 | |
| Janssen Pharmaceuticals, INC | $194.49 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $162.19 | 2022 | |
| Janssen Biotech, INC. | $160.08 | 2025 | |
| Vanda Pharmaceuticals INC. | $148.11 | 2024-2025 | Ponvory |
| Ucb, INC. | $147.95 | 2019-2025 | Briviact, Nayzilam |
| Adamas Pharmaceuticals, INC. | $118.99 | 2020-2021 | |
| Livanova USA, INC. | $115.23 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Argenx US, INC. | $109.41 | 2022-2024 | Vyvgart, Vyvgart Hytrulo |
| Allergan, INC. | $109.00 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $98.88 | 2022 | |
| Jazz Pharmaceuticals INC. | $92.94 | 2022-2025 | |
| Genzyme Corporation | $81.80 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $79.49 | 2023-2024 | Rexulti |
| Medtronic, INC. | $79.22 | 2025 | Percept PC Brainsense |
| Azurity Pharmaceuticals, INC. | $72.61 | 2024 | Horizant |
| Octapharma USA, INC. | $60.00 | 2023-2024 | Panzyga, Octagam Immune Globulin (Human) |
| Boston Scientific Corporation | $53.91 | 2024-2025 | Vercise |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $49.18 | 2023 | Rexulti |
| Impel Pharmaceuticals INC. | $46.91 | 2023 | Trudhesa |
| Grifols USA, LLC | $42.33 | 2024-2025 | Gamunex-C |
| Assertio Therapeutics, INC. | $40.28 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $38.97 | 2023-2024 | Aptiom |
| Supernus Pharmaceuticals, INC. | $37.98 | 2020-2021 | |
| Csl Behring | $33.08 | 2023 | Hizentra |
| Avion Pharmaceuticals | $31.11 | 2023 | Dhivy |
| Cycle Pharmaceuticals INC | $30.75 | 2025 | Tascenso Odt, Bafiertam |
| Catalyst Pharmaceuticals, INC. | $29.44 | 2025 | |
| Upsher-Smith Laboratories LLC | $27.60 | 2020 | |
| Ge Healthcare | $24.11 | 2025 | |
| Collegium Pharmaceutical, INC. | $18.84 | 2022 | |
| Amneal Pharmaceuticals LLC | $18.39 | 2023 | Rytary |
| Arbor Pharmaceuticals, INC. | $16.80 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.80 | 2023 | Quviviq |
| Ani Pharmaceuticals, INC. | $14.96 | 2024 | Purified Cortrophin Gel |
| Acorda Therapeutics, INC | $13.80 | 2020 | |
| Sunovion Pharmaceuticals INC. | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurence Bower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.